Debra Dursobumpus Net Worth & Insider Trades

Debra Dursobumpus - CHIEF PEOPLE OFFICER, Blueprint Medicines Corp

As of August 26, 2022

What is Debra Dursobumpus's Net Worth?

The current estimated net worth of Blueprint Medicines Corp's CHIEF PEOPLE OFFICER, Debra Dursobumpus, is estimated to be about $3.12M . Debra Dursobumpus owns about 40,836 units of Blueprint Medicines Corp common stock. In the last 2 years at Blueprint Medicines Corp, Debra Dursobumpus has sold an estimated value of $1.92M worth.

What is Debra Dursobumpus's Past Insider Trading?

Debra Dursobumpus's largest purchase order was 5,177 units , worth over $151.88K on November 3, 2021. Debra Dursobumpus's largest sale order was 5,177 units , worth over $585.17K on November 3, 2021. In total, Debra Dursobumpus has made about 12 transactions over 2 years of their time at Blueprint Medicines Corp. Debra Dursobumpus usually trades in March, with the busiest year in 2020. The most recent transaction was a sale order of 5,000 units , worth over $375.55K on August 26, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Debra Dursobumpus's' Mailing Address?

  • Mailing address is C/o Blueprint Medicines Cororation 45 Sidney Street Cambridge MA 02139 MA

Blueprint Medicines Corp Executive Compensation

Name
Year
Salary
Total
Jeffrey W. Albers 2020 $645,000 $6,344,667
Jeffrey W. Albers 2019 $590,000 $9,362,371
Jeffrey W. Albers 2018 $541,144 $9,740,799
Michael Landsittel 2020 $379,575 $2,014,974
Michael Landsittel 2019 $345,000 $1,958,720
Michael Landsittel 2018 $281,678 $1,740,610
Fouad Namouni, M.D. 2020 $186,154 $6,668,732
Fouad Namouni, M.D. 2019 - -
Fouad Namouni, M.D. 2018 - -
Kathryn Haviland 2020 $460,944 $2,363,556
Kathryn Haviland 2019 $431,830 $3,090,423
Kathryn Haviland 2018 $392,589 $2,601,762
Tracey L. McCain, Esq. 2020 $453,301 $2,346,428
Tracey L. McCain, Esq. 2019 $437,972 $2,900,568
Tracey L. McCain, Esq. 2018 $425,216 $2,647,962
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm

What are Blueprint Medicines Corp's Past Insider Trades?

Blueprint Medicines Corp's most recent insider trade came on August 26, 2022 by Debra Dursobumpus who sold 5,000 units worth $375.55K . In the last 7 years, insiders at Blueprint Medicines Corp have sold an estimated value of $172.49M and bought an estimated value of $17.41M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Jeffrey Albers,  Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER,  and Kate Haviland, CHIEF OPERATING OFFICER .

Blueprint Medicines Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1